Search Legislation

Commission Decision of 23 July 2001 on additional guarantees in intra-Community trade of pigs relating to Aujeszky's disease, criteria to provide information on this disease and repealing Decisions 93/24/EEC and 93/244/EEC (notified under document number C(2001) 2236) (Text with EEA relevance) (2001/618/EC) (repealed)

 Help about what version

What Version

 Help about advanced features

Advanced Features

 Help about UK-EU Regulation

Legislation originating from the EU

When the UK left the EU, legislation.gov.uk published EU legislation that had been published by the EU up to IP completion day (31 December 2020 11.00 p.m.). On legislation.gov.uk, these items of legislation are kept up-to-date with any amendments made by the UK since then.

Close

This item of legislation originated from the EU

Legislation.gov.uk publishes the UK version. EUR-Lex publishes the EU version. The EU Exit Web Archive holds a snapshot of EUR-Lex’s version from IP completion day (31 December 2020 11.00 p.m.).

Status:

Point in time view as at 04/11/2005.

Changes to legislation:

There are currently no known outstanding effects for the Commission Decision of 23 July 2001 on additional guarantees in intra-Community trade of pigs relating to Aujeszky's disease, criteria to provide information on this disease and repealing Decisions 93/24/EEC and 93/244/EEC (notified under document number C(2001) 2236) (Text with EEA relevance) (2001/618/EC) (repealed), Division 2.. Help about Changes to Legislation

Close

Changes to Legislation

Revised legislation carried on this site may not be fully up to date. At the current time any known changes or effects made by subsequent legislation have been applied to the text of the legislation you are viewing by the editorial team. Please see ‘Frequently Asked Questions’ for details regarding the timescales for which new effects are identified and recorded on this site.

2.Standardisation, sensitivity and specificity of the test.U.K.

(a)

The sensitivity of the test must be of such a level that the following Community reference sera are scored positive:

  • Community reference serum ADV 1 at 1:8 dilution,

  • Community reference serum ADV-gE A,

  • Community reference serum ADV-gE B,

  • Community reference serum ADV-gE C,

  • Community reference serum ADV-gE D,

  • Community reference serum ADV-gE E,

  • Community reference serum ADV-gE F.

(b)

The specificity of the test must be of such a level that the following Community reference sera are scored negative:

  • Community reference serum ADV-gE G,

  • Community reference serum ADV-gE H,

  • Community reference serum ADV-gE J,

  • Community reference serum ADV-gE K,

  • Community reference serum ADV-gE L,

  • Community reference serum ADV-gE M,

  • Community reference serum ADV-gE N,

  • Community reference serum ADV-gE O,

  • Community reference serum ADV-gE P,

  • Community reference serum ADV-gE Q.

(c)

For batch control, Community reference serum ADV 1 must be scored positive at 1:8 dilution and one of the Community reference serum sera from ADV-gE G to ADV-gE Q, as listed in point (b), must be scored negative.

For batch control of ADV-gB and ADV-gD kits, Community reference serum ADV 1 must be scored positive at the dilution of 1:2 and Community reference serum Q referred to in (b) should be scored negative.

(d)

The institutes listed below will, in addition, be responsible for checking the quality of the ELISA method in each Member State, and in particular for producing and standardising national reference sera according to the Community reference sera.

  • Belgium — Centre de Recherches vétérinaires et agrochimiques, 1180 Bruxelles;

  • Denmark — Statens veterinære Institut for Virusforsknig, Lindholm, 4771 Kalvehave;

  • Germany — Bundesforschungsanstalt für Viruskrankheiten der Tiere, 16868 Wusterhausen,

  • Greece — Veterinary Institute of Infectious and Parasitic Diseases, 15310 Ag. Paraskevi,

  • Spain — Laboratorio Central de Veterinaria de Algete, Madrid,

  • France — École nationale vétérinaire, Alfort, 94704 Maisons-Alfort,

  • Ireland — Veterinary Research Laboratory, Abbotstown, Castleknock, Dublin 15,

  • Italy — Istituto Zooprofilattico Sperimentale della Lombardia a dell'Emilia-Romagna, Brescia,

  • Luxembourg — Laboratoire de Médecine Vétérinaire de l'État, 1020 Luxembourg,

  • The Netherlands — Instituut voor Veehouderij en Diergezondheid (ID-DLO), 8200 AB Lelystad,

  • Austria — Bundesanstalt für veterinärmedizinische Untersuchungen in Mödling, 2,40 Modling,

  • Portugal — Laboratório Nacional de Investigaão Veterinária, 1500 Lisboa,

  • Finland — Eläinlääkintä- ja elintarviketutkimuslaitos, 00581 Helsinki,

  • Sweden — Statens veterinarmedicinska anstalt, 75189 Uppsala,

  • United Kingdom — Veterinary Laboratory Agency, New Haw, Weybridge, Surrey KT15 3NB.

Back to top

Options/Help

Print Options

Close

Legislation is available in different versions:

Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.

Original (As adopted by EU): The original version of the legislation as it stood when it was first adopted in the EU. No changes have been applied to the text.

Point in Time: This becomes available after navigating to view revised legislation as it stood at a certain point in time via Advanced Features > Show Timeline of Changes or via a point in time advanced search.

Close

See additional information alongside the content

Geographical Extent: Indicates the geographical area that this provision applies to. For further information see ‘Frequently Asked Questions’.

Show Timeline of Changes: See how this legislation has or could change over time. Turning this feature on will show extra navigation options to go to these specific points in time. Return to the latest available version by using the controls above in the What Version box.

Close

Opening Options

Different options to open legislation in order to view more content on screen at once

Close

More Resources

Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:

  • the original print PDF of the as adopted version that was used for the EU Official Journal
  • lists of changes made by and/or affecting this legislation item
  • all formats of all associated documents
  • correction slips
  • links to related legislation and further information resources
Close

Timeline of Changes

This timeline shows the different versions taken from EUR-Lex before exit day and during the implementation period as well as any subsequent versions created after the implementation period as a result of changes made by UK legislation.

The dates for the EU versions are taken from the document dates on EUR-Lex and may not always coincide with when the changes came into force for the document.

For any versions created after the implementation period as a result of changes made by UK legislation the date will coincide with the earliest date on which the change (e.g an insertion, a repeal or a substitution) that was applied came into force. For further information see our guide to revised legislation on Understanding Legislation.

Close

More Resources

Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:

  • the original print PDF of the as adopted version that was used for the print copy
  • correction slips

Click 'View More' or select 'More Resources' tab for additional information including:

  • lists of changes made by and/or affecting this legislation item
  • confers power and blanket amendment details
  • all formats of all associated documents
  • links to related legislation and further information resources